diagnostic medical device News
-
Atmo Biosciences wins Early Stage Investment Forum at AusBiotech
Atmo Biosciences beat 10 other contenders to win the Early Stage Investment Forum (ESIF) at AusBiotech 2019, held at the Melbourne Convention Centre last week. The ESIF is a key element of the annual AusBiotech conference featuring short pitches from SMEs and research institutions on early stage biotech technology and projects covering areas such as: Human therapeutics Diagnostics Medical ...
-
CeQur Appoints Peter B. Luther to Board of Directors
CeQur® announced the appointment of Peter B. Luther to its board of directors, effective immediately. Luther is a 29-year veteran of the medical device and diagnostics, OTC drugs and consumer-packaged goods industries. ...
-
Noleus Wins Audience Choice at MedTech Innovator Pitch Event
Noleus Technologies won the audience choice award at the MedTech Innovator Houston Pitch Event. The event was hosted at the Johnson and Johnson Innovation JLABS@TMC event space. According to the MedTech Innovator website, these events "feature pitches from best-in-class medical device, diagnostic, and digital health companies vying for a spot in the 2018 program." Judging from local experts in ...
-
Moray Medical named a Rosenman Innovator
An esteemed panel of subject matter experts, clinicians, and investors selected Moray Medical (then called Project Moray) as a Rosenman Innovator for its innovative technology and patient impact, digitizing the user interface of cardiac catheter systems to enable precise delivery of therapies within the beating hearts of millions of patients. The UCSF Rosenman Institute, a health technology ...
-
Vice President of Product Marketing Tommy Carls Featured in Medical Device and Diagnostic Industry
Proprio’s vice president of product management and marketing, Tommy Carls, has been featured in Medical Device and Diagnostic Industry (“MD&DI”). Carls’ thought leadership piece, “Bringing Intentionality & Defined Purpose to the Road to Data Intelligence” highlights the undervalued influence of healthcare data, and the potential impacts of more ...
-
Waters ACQUITY UPLC I-Class/Xevo TQ-S micro System available as a U.S. FDA Class I, CE-Marked Medical Device
Waters Corporation (NYSE: WAT) today announced that the Waters® ACQUITY UPLC® I-Class IVD/Xevo® TQ-S micro IVD System is now manufactured as a U.S. FDA Class I medical device and is CE Marked to the European Directive 98/79/EC (IVDD). This development allows clinical laboratories to access leading innovations in liquid chromatography (LC) and mass spectrometry (MS) technology for the ...
-
PerkinElmer Appoints Aaron Geist as Vice President, Business Development
Extensive Health Sciences Industry Experience Will Drive Company's Business Development Strategy BOSTON - Jan. 19, 2006 - PerkinElmer, Inc. (NYSE: PKI), a global technology leader in the health sciences and photonics markets, today announced the appointment of Dr. Aaron Geist as Vice President, Business Development for the Company. Dr. Geist will be responsible for developing ...
-
The Centers for Medicare and Medicaid (CMS) announced the MCIT pathway to provide national Medicare coverage for FDA Breakthrough Devices and Diagnostic
The Centers for Medicaid and Medicare (CMS) announced the establishment of the MCIT (Medicare Coverage of Innovative Technology) pathway, which is designed to provide coverage and access to new, innovative medical devices and diagnostics which have received FDA Breakthrough Device Designation to Medicare beneficiaries nationwide. Through this pathway, Breakthrough devices will automatically be ...
-
Peer-Reviewed Journal Publishes PrecivityAD™ Blood Test Research, Confirming Its Role in Assisting Clinicians in Alzheimer’s Diagnosis
A peer-reviewed journal has published the first research paper to state that the PrecivityAD™ blood test “can accurately identify brain amyloid status based on a single blood sample.” The research paper in Molecular Neurodegeneration adds that the test’s “excellent performance” for Alzheimer’s disease (AD) diagnosis allows for “improved medical ...
-
Bruker Appoints Robert Rosenthal to Board of Directors
Bruker Corporation (NASDAQ:BRKR) today announced that it has appointed Dr. Robert Rosenthal to its Board of Directors, effective immediately. Dr. Rosenthal currently serves as Chief Executive Officer and as a director for Taconic Biosciences, Inc., a privately-held provider of research models for the pharmaceutical and biotech industry, a position he has held since joining Taconic Biosciences in ...
-
Anavasi Diagnostics Announces Appointment of Scott Robitaille As Vice President Of Sales And Marketing
Anavasi Diagnostics ('Anavasi'), a medical technology company focused on the development of novel molecular diagnostic testing, has announced the addition of Scott Robitaille as Vice President of Sales & Marketing. Robitaille joins Anavasi with in-depth knowledge of the medical device and molecular diagnostics sector and over two decades of sales, marketing, and channel management ...
-
Borealis appoints IMCD as Bormed healthcare portfolio distributor
Distribution agreement to take effect as of 1 October 2021 New agreement applies to Bormed™ portfolio of innovative polyolefin grades for healthcare Complementary Borealis and IMCD product portfolios to enable even more choice in polymers Borealis announces that it has selected IMCD, a global leader in the distribution of specialty chemicals and ingredients, as its new European ...
By Borealis AG
-
Eg Technology And Health Enterprise East Announce Winners Of The 2021 Innovation Voucher Award
Following the success of the 2020 Innovation Voucher Award, won by Mr Ryan Mathew and Dr Heiko Wurdak for their Mini-brain benchtop test, eg technology and Health Enterprise East (HEE) are pleased to announce, not one, but two joint winners of this year’s Innovation Voucher Award. Having received numerous applications covering a fascinating range of emerging medical technologies, this ...
-
Third Pole Therapeutics Names Bill Athenson New CEO
Third Pole Therapeutics, a privately held company developing and delivering transformative life-saving cardio-pulmonary therapies, has named seasoned healthcare executive Bill Athenson as its new Chief Executive Officer, the company announced today. David Zapol, Third Pole’s founding CEO, will continue providing strategic counsel to Third Pole. Athenson joins Third Pole building on the ...
-
3DBio Therapeutics Receives FDA Rare Pediatric Disease Designation for AuriNovo™ for Ear Reconstruction in Microtia Patients
3DBio Therapeutics, an emerging leader in the field of 3D-bioprinting for human therapeutic use, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation for AuriNovo™, an investigational combination product for reconstruction of the outer ear in patients with microtia. Microtia is a rare congenital disorder causing the outer ear ...
-
CorWave Wins 2021 Healthtech Award
CorWave, a French medtech company developing a nextgeneration heart pump, won the 2021 Healthtech Award in the Medtech category yesterday. Organized by France Biotech, the French professional association of healthtech entrepreneurs, the event rewards the companies that have made the biggest impact on the sector this year. 109 companies submitted applications for the 2021 Healthtech Awards. ...
By CorWave
-
BSI extends healthcare rReach with Eurocat acquisition
BSI, the global standards and assessment body, has acquired German healthcare certification and testing business, EUROCAT. This development significantly enhances BSI’s ability to service the medical device market globally.EUROCAT is an established Notified Body offering healthcare systems and product certification. The company has a significant presence in Germany - the third largest medical ...
-
LSI Emerging Medtech Summit Will Spotlight 100 Innovative Startups to Audience of Investors & Strategic Partners
Life Science Intelligence (LSI) is hosting the Emerging Medtech Summit February 18-20th, 2020 at The Ritz-Carlton in Laguna Niguel, CA. The event is drawing attendance from major medtech investors and strategics looking to partner with new medical device, diagnostic, digital health and other healthtech innovators. In addition to startup CEO presentations, the event will include panel discussions ...
By Strados Labs
-
Woolsey Pharmaceuticals’ Financing is Oversubscribed; Two Board Members Named
NEW YORK, NY – March 11, 2020 – Woolsey Pharmaceuticals announced today that it completed a round of financing that will fund operations through the completion of a planned clinical study. The amount was not disclosed but the financing was substantially oversubscribed, according to company officials. The Company also announced the appointment of two outside board members, David ...
-
PixCell Medical Announces Acquisition by Soulbrain Holdings
PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that Soulbrain Holdings has acquired all controlling PixCell shares, as well as investing in the company, making Soulbrain the majority shareholder of PixCell Medical. The acquisition of PixCell aligns with Soulbrain's recent strategic transition into the healthcare and in-vitro diagnostics space. ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you